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included in its registry. We assessed the INTERMACS (IMCS) classification
in patients admitted in an ICU with cardiogenic shock.
Methods: Consecutive patients with cardiogenic shock on admission who
were admitted in a tertiary hospital ICU. IMCS status was assessed at within
the first 24 hours and 96 hours after admission. Outcomes (bi-ventricular
assist device (BiVAD), heart transplantation (HT) and mortality) were
recorded in hospital and at 3 and 12 months.
Results: The study included 87 patients (median age 60 [IQR:54-69]
years). 41 (47%) patients had IABP and 27 (31%) were on mechanical venti-
lation. At 24 hours after admission, 7 patients (8.04%) with IMCS Profile 1
(critical cardiogenic shock), 18 (20.6%) with IMCS Profile 2 (sliding on ino-
tropes) and 62 (71.3%) with IMCS Profile 3 (dependant on inotropes). Results
are presented in the table.
Conclusion: In patients with cardiogenic shock, the INTERMACS classi-
fication is an easy way to classify patient's risk during the first 24 hours. Evo-
lution of IMCS profiles allows to assess response to treatment over time. It
may present as a useful tool in the ICU to discuss early the best strategies to
manage cardiogenic shocks. 
Table – Results
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The use of drugs is the subject of numerous recommendations. Most of
sudden cardiac deaths (SD) are related to a ventricular fibrillation (VF) and
ischemic heart disease, but some of them are drug-related. The purpose of
study was to evaluate the prevalence of drug-related SD’s and the possible
changes during these past 20 years.
Methods: 239 patients, 181 men, 58 women, aged from 12 to 88 years
(61±15) were admitted after SD resuscitation outside the acute phase of myo-
cardial infarction, 139 before 2000 (group I), 100 between 2000 and 2010
(group II). Clinical data, treatment, electrolytes, echocardiography, Holter
ECG, exercise testing, electrophysiological study (EPS), evaluation of coronary
status and ergonovine test when coronary arteries were normal, were collected.
Results: The causes of resuscitated SD’s did not change significantly
during these 2 periods. The presence or not of heart disease (HD) did not
differ: 34 group I patients (24%) and 34 group II patients (34%) had no
apparent (HD)(NS). Ischemic HD, idiopathic dilated cardiomyopathy, valvular
HD, coronary spasm, various HD’s, preexcitation syndrome or ion channel
disorders were as frequent in group I (42%, 11.5%, 12%, 3%, 3.5%, 4%) as
in group II (34%, 11%, 6%, 4%, 6%, 5%). Drug-related SD’s did not change
during these periods: 38 patients presented a drug-related VT/VF or asystole
with cardiac arrest, 20 (14%) before 2000 and 18 patients (18%) since 2000.
SD was caused by hypokaliema or increase of QT interval or a major conduc-
tion disturbance. HD or abnormal ECG was present in 20 patients. Digoxin,
diuretics, calcium inhibitors, betablockers, antiarrhythmic drugs alone or in
association were the implicated drugs.
Conclusion: Drug-related arrhythmias continue to explain at least 15% of
SD’s. Despite the publication of numerous recommendations on the use of
drugs, the number of fatal events that may be attributed to a cardiovascular
drug did not decrease between the years before 2000 and after 2000. 
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Introduction: An increased risk of malignant arrhythmias may exist following
electrocution and electrocuted patients are routinely hospitalized in intensive care
unit (ICU) for monitoring. The purpose of this study was to evaluate the short-
term incidence of arrhythmias and sudden death in electrocuted patients.
Methods: This monocentric retrospective study included all patients hos-
pitalized between January 2005 and November 2010 in ICU at Cochin hos-
pital (Paris, France).
Results: We enrolled 31 consecutive patients (mean age 33±15 years, 74%
men). Electrocution was due to domestic current (alternating current, 230V single-
phase, 50Hz of frequency) in 65% of cases. Electrocution was a work related acci-
dent in 70% of cases. Superficial burns were observed in 87% of patients. Cardiac
troponin Ic level (normal range <0.04 μg/ml) was found to be elevated in 16% of
patients (mean 0,09±0,03 μg/ml) and creatinine kinase level was found to be
increased in 55% of patients (426±713 UI/l). Electrocardiogram abnormalities
were noticed in 84% of cases (ventricular hypertrophy in 11, incomplete bundle
branch block in 9, diffuse ST-segment elevation in 6, and negative T waves in inf-
erolateral leads in 13). Echocardiography was performed in 6% of patients and
revealed mild septal hypertrophy (mean 13±2 mm) without segmental wall-
motion abnormalities. During a mean ICU stay of 1±0.5 day, none of the patients
presented atrial or ventricular arrythmias nor sudden death. During a mean follow-
up of 30±10 months, 29% of patients were lost and the remaining 71% did not
present physical or psychological sequelae related to electrocution.
Conclusion: In our study, the initial course of all electrocuted patients was
uneventful. These results suggest that systematic hospitalization in ICU may
not be mandatory after electrocution.
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Background: recent improvements in the management of out-of-hospital
cardiac arrest (OHCA) should allow a better prognosis. This study aims at
Best IMC Profile 
within the first 
24 hours
IMCS (n=7)
Profile 1 
IMCS (n=18)
Profile 2
IMCS (n=62)
Profile 3
Ischemic 
myocardiopathy
3(42.9%) 12(66.7%) 28(45.2%)
Median age 
(yr.-IQ)
57(5.5) 62(16) 58(7)
Evolution 
24-96 hours: Died
5 4 1
Evolution 
24-96 hours:
 BiVAD pr HT
1 2 3
Alive without 
BiVAD or HT 
at the 96th hour
1(14%) 12(66.6%) 58(93.5%)
Evolution in ICU 
after the 96th hour
Died 4 4
BiVAD or HT 4 4
Discharged from 
ICU without BiVAD 
or HT
1(14%) 4(22%) 47(75.8%)
3-months 
mortality
n=5(71%) n=12(67%) n=21(34%)*
1-year mortality n=6(86%) n=12(67%) n=27(44%)*
*p values <0.05 Profile 3 vs 2, Profile 3 vs 1
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determining the characteristics and prognosis of patients treated by hypothermia
in a Cardiac Intensive Care Unit of a French University Hospital for an OHCA.
Methods: We analyzed data of patients admitted during the 3 last years
(2008-10) for management of an OHCA related to a ventricular arrhythmia,
by therapeutic hypothermia. Main characteristics were compared according to
the intra hospital outcome.
Results: During the inclusion time, 53 patients (mean age: 58±15; male:
48 (90%)) were enrolled, included 18 STEMI (34%). Mean resuscitation
delays were: “no flow” 4.4±6, “low flow” 23.2±16 minutes. Comparison of
main data according to the intra hospital outcome (“Good outcome” group are
patient discharged with good cerebral performance or moderate cerebral dis-
ability) is presented in table 1.
Conclusion: prognosis of OHCA is still poor. Factors associated with good
prognosis are: male gender, short delays of resuscitation (“no flow” and “low
flow”), low lactate blood, coronary artery disease on the admission angio-
graphy and angioplasty.
Table – Comparison of main data according to the intra hospital outcome.
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Prasugrel a new thienopyridine inhibits adenosine diphosphate induced
platelet aggregation more rapidly, more consistently, and to a greater extent
than do standard and higher doses of clopidogrel.
The aim of this study was to compare the effect of pre-hospital treatment
with prasugrel and clopidogrel on the TIMI flow in patients admitted in cath
lab with acute STEMI in 2010. The primary efficacy endpoint was the supe-
riority of TIMI flow in patients pretreated with prasugrel and reduction of use
of Glycoprotein IIb/IIIa inhibitors in primary PCI. The key safety endpoint
was tolerance of prasugrel and bleeding.
The primary efficacy endpoint occurred in 41% of patients receiving pra-
sugrel and 33% of patients receiving clopidogrel (p=0.251).The subgroup (ST
elevation within 6h ) had the maximal profit of TIMI FLOW with 44.1% in
the prasugrel arm compared with 27.4% in the clopidogrel arm (p=0.088). No
difference in the term of reduction of Glycoprotein IIB/IIIa inhibitors use in
primary PCI (p=0.352). The patients receiving prasugrel had a very good tol-
erance without elevation in rates of major bleeding.
In conclusion, there was no significant difference in term of TIMI Flow
and use of Inhibitors of Glycoprotein IIb/IIIa in primary PCI between the pra-
sugrel and clopidogrel groups. The patients presenting within 6h of ST seg-
ment elevation had a better TIMI flow if pretreated with prasugrel (P=0.088)
with 16.67% gain in good TIMI flow in favor of prasugrel. More studies are
needed.
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Background: New troponin assays achieve early high sensitivity. A normal
single high sensitive (HS) troponin at time of admission might rule out acute
coronary syndrome.
Methods: Patients with acute chest pain and low to intermediate likelihood
of coronary artery disease were referred to a dedicated protocol in our chest
pain unit. Patients with normal initial EKG and no noticeable alternative cause
than ACS were evaluated by a single Troponin I test (Vitros I ES assay,
threshold 0.012 ng/mL, 99th percentile 0.034 ng/mL) at time of admission. All
patients with normal HS troponin were referred to coronary computed tomog-
raphy (CCT) angiography within 3 hours (General Electric 64-detectors Scan).
Patients with suspected coronary obstruction by CCT were admitted and HS
troponin aditionnally tested between 6 and 24 hours.
Results: Sixty eight patients (54+/–13 years) referred to our chest pain unit
showed normal initial Troponin and EKG. Pre test- likelihood for coronary
artery disease was 58%+/–24%. CCT was performed and coronary angiog-
raphy reconstruction was evaluable in all patients. CCT showed significant
obstruction (>50% stenosis) in 13 patients (19%). Invasive coronary angiog-
raphy was performed and confirmed significant obstrution in 8 patients (12%).
Multivessel disease was observed in 6 and TIMI flow was <3 in 3. Serial
troponin sampling showed HS troponin elevation in only one patient.
Conclusions: In low risk patients with acute chest pain, a normal single HS
troponin sample does not rule out acute coronary syndrome. Increasing patient
detection is more efficiently performed by Coronary CT at time of admission
than HS troponin serial sampling.
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Two large studies recently related that the combination of copeptin and
troponin had a remarkable negative predictive value to rule out myocardial
infarction (MI).
Good 
outcome
Group
n=22
Poor 
outcome
Group
n=31
p
Clinical Male 22 (100) 26 (83) 0.04
Age 55 ±13 60±16 0.27
Diabetes mellitus 3 (13) 4 (13) 0.93
Current smoker 6 (27) 9 (29) 0.88
Known cardiopathy 9 (41) 21 (67) 0.052
Anamnesis
of the cardiac 
arrest and 
management
Time of occurring
(6 am-6 pm)
16 (72) 22 (71) 0.28
“No flow” delay 
(minutes)
2 ±3 5 ±6 0.039
“Low flow” delay 
(minutes)
15 ±14 29 ±16 0.003
STEMI 10 (45) 9 (29) 0.21
Coronary artery 
disease on the admission 
angiography
18 (81) 16 (51) 0.02
Angioplasty 13 (59) 4 (13) <0.001
Delay between OHCA 
and beginning 
of hypothermia (minutes)
181 ±78 233 ±113 0.08
Biomarkers
at the admission
Troponin (ng/ml) 12.7±30 3.1 ±4 0.09
Lactate blood (mmol/l) 2.4 ±1 4.0 ±2 0.009
pH 7.33 ±0.1 7.29 ±0.1 0.18
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